| EU number | Indication |
| EU/3/24/2914 | Treatment of neuroblastoma |
| EU/3/24/2909 | Treatment of spinal cord injury |
| EU/3/24/2913 | Treatment of ataxia-oculomotor apraxia |
| EU/3/24/2912 | Treatment of congenital pseudarthrosis of long bones |
| EU/3/24/2911 | Treatment of Duchenne muscular dystrophy |
| EU/3/24/2910 | Treatment of acute myeloid leukaemia |